
The Indian government has initiated a tender process to acquire patents for 17 rare disease medications. This move aims to enhance accessibility and affordability of crucial treatments for individuals suffering from these debilitating conditions. By securing patents, the government intends to facilitate domestic production of these drugs, potentially lowering costs and ensuring a consistent supply within the country. This initiative reflects a significant step towards improving healthcare outcomes for patients with rare diseases in India. For more information read this article.
Details
- Publication date
- 21 November 2024 (Last updated on: 20 January 2025)
- Author
- European Innovation Council and SMEs Executive Agency